Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry

Amaryllidaceae Isocarbostyril Alkaloids and Their Derivatives as Promising Antitumor Agents

(2014) Laurent Ingrassia et al.   Translational Oncology

Vascular endothelial-cadherin and vascular stability

(2012) Elisabetta Dejana et al.   CURRENT OPINION IN HEMATOLOGY

A new paradigm tumor for drug development

(2012) Alexander M. M. Eggermont et al.   Nature Reviews Clinical Oncology

Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer

(2011) Armelle Guelte et al.   BIOLOGY OF THE CELL

Basic and Therapeutic Aspects of Angiogenesis

(2011) Michael Potente et al.   CELL

New Strategies in Metastatic Melanoma: Oncogene-Defined Taxonomy Leads to Therapeutic Advances

(2011) K. T. Flaherty et al.   CLINICAL CANCER RESEARCH

New drugs in melanoma: It’s a whole new world

(2011) Alexander M.M. Eggermont et al.   EUROPEAN JOURNAL OF CANCER

Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: One step forward for overcoming anti-angiogenic drug resistance?

(2011) Iris Helfrich et al.   Molecular Oncology

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Antiangiogenic therapy: impact on invasion, disease progression and metastasis

(2011) John M. L. Ebos et al.   Nature Reviews Clinical Oncology

Antitumour immunity mediated by mannan-modified adenovirus vectors expressing VE-cadherin

(2011) Zhiwei Zhao et al.   VACCINE

Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?

(2010) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Amaryllidaceae Alkaloids Belonging to Different Structural Subgroups Display Activity against Apoptosis-Resistant Cancer Cells†

(2010) Gwendoline Van Goietsenoven et al.   JOURNAL OF NATURAL PRODUCTS

Lycorine and its Derivatives for Anticancer Drug Design

(2010) D. Lamoral-Theys et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Small molecules and targeted therapies in distant metastatic disease

(2009) P. Hersey et al.   ANNALS OF ONCOLOGY

Tumor Angiogenesis in Melanoma

(2009) Alexander G. Marneros   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma

(2009) Luis H. Camacho et al.   JOURNAL OF CLINICAL ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Lycorine, the Main Phenanthridine Amaryllidaceae Alkaloid, Exhibits Significant Antitumor Activity in Cancer Cells That Display Resistance to Proapoptotic Stimuli: An Investigation of Structure−Activity Relationship and Mechanistic Insight

(2009) Delphine Lamoral-Theys et al.   JOURNAL OF MEDICINAL CHEMISTRY

Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality

(2009) Quansheng Zhou et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells

(2009) Gian Carlo Alghisi et al.   PLoS One

Endoscopic resection with ligation using a multi-band mucosectomy system in Barrett’s esophagus with high-grade dysplasia and intramucosal carcinoma

(2009) Yasser M. Bhat et al.   Therapeutic Advances in Gastroenterology

Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry

(2008) Alexandra A. Mourad-Zeidan et al.   AMERICAN JOURNAL OF PATHOLOGY

Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells

(2008) Xiao-shan Liu et al.   CANCER LETTERS

Breaking the VE-cadherin bonds

(2008) Julie Gavard   FEBS LETTERS

The role of adherens junctions and VE-cadherin in the control of vascular permeability

(2008) E. Dejana et al.   JOURNAL OF CELL SCIENCE

Kaposi's Sarcoma-Associated Herpesvirus Disrupts Adherens Junctions and Increases Endothelial Permeability by Inducing Degradation of VE-Cadherin

(2008) L.-W. Qian et al.   JOURNAL OF VIROLOGY

Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine

(2008) Quansheng Zhou et al.   METHODS

VE-Cadherin

(2007) Dietmar Vestweber   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY